FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Real-time Bid/Ask 13:25:44 2024-06-06 EDT | ||
| 4.74 EUR / 4.75 EUR | +5.92% |
|
| Current month | -20.85% | ||
| 1 month | -37.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 4.84 | +8.04% |
| 24-06-05 | 4.48 | -6.08% |
| 24-06-04 | 4.77 | -7.92% |
| 24-06-03 | 5.18 | -8.48% |
| 24-05-31 | 5.66 | -11.15% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 12:58 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK7Z4V |
| ISIN | DE000JK7Z4V6 |
| Date issued | 2024-04-26 |
| Strike | 295.9 $ |
| Maturity | Unlimited |
| Parity | 12.43 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.04 € |
|---|---|
| Lowest since issue | 4.48 € |
| Spread | 0.01 € |
| Spread % | 0.21% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
236.7
USD
Average target price
284.8
USD
Spread / Average Target
+20.30%
- Stock Market
- Certificates
- Certificat
